Evotec bags US$23.8m to fight tuberculosis
Evotec SE entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens that better address...
UK biotech to make proteins from carbon dioxide emissions
According to the deal announced in mid-June, Deep Branch Biotechnology will place a pilot plant within Drax’s Carbon Capture Usage and Storage...
EU ministers set to exclude CRISPR crops from GMO legislation
Following a proposal from the Netherlands supported by Estonia, Denmark and Belgium, presented in Brussels, EU agriculture ministers seem decided to...
Chiesi acquires ex-US Raxone marketing rights
The deal - worth up to CHF105m (€93m) including sales milestones – gives Santhera financial backing to advance its the development of its...
Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal
NASH, which has a high prevalence in the growing patient population of diabetics and obese people, often starts with the accumulation of fat in the...
Hedging success
Setting the tone: successful entrepreneur Jean-Paul Clozel (Idorsia, formerly Actelion) warned of taking upcoming threats like populism too lightly....
Better TNF∝ receptor blockers on the horizon
Penny Morton and colleages from Kings College in London uncovered how the organisation of the receptor for tumor necrosis factor ∝(TNFR1) within the...